Clinical Trials for Bladder Cancer

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

NCT ID: NCT06834204

This clinical trial is studying a new way to help cancer survivors who also have other health issues, like high blood pressure or diabetes. The goal is to see if a special program called Primary Ca...

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients with Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

NCT ID: NCT05037279

This clinical trial is studying a new treatment called Verity-BCG for patients with intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) who have never received a type of treatment...

Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer

NCT ID: NCT06493370

This clinical trial is studying a new treatment approach for patients with muscle invasive bladder cancer (MIBC) who are unable or unwilling to use cisplatin, a common chemotherapy drug. The resear...

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT ID: NCT05864144

This clinical trial is studying a new treatment called SNS-101, which is an antibody designed to help the immune system fight against certain advanced solid tumors. It will be tested on its own and...

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

NCT ID: NCT05337189

This clinical trial is studying a new urine test called the Human Multigene Methylation Detection Kit, which aims to help diagnose bladder cancer more effectively. The researchers want to see how s...

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

NCT ID: NCT06571708

This clinical trial, called NeoSTOP-IT, is investigating a new treatment approach for adults with localized muscle-invasive bladder cancer. The researchers want to find out if a combination of thre...

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

NCT ID: NCT06337942

This clinical trial is exploring the possibility of bladder transplantation for patients suffering from severe bladder diseases, such as bladder cancer or kidney failure. The main aim is to see if ...

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

NCT ID: NCT06281080

This clinical trial is testing a new robotic system called Zenith, designed to help doctors remove bladder tumors more effectively. The study aims to see if this system is safe and works well for p...

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT ID: NCT03317158

This clinical trial is looking at the use of a new treatment called durvalumab for patients with specific types of bladder cancer that have not responded to standard treatments like BCG therapy. Th...

Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer

NCT ID: NCT06775977

This clinical trial is studying a new method for accurately diagnosing the stage of bladder cancer before surgery using a special ultrasound technique called contrast-enhanced ultrasound (CEUS). Th...

Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02

NCT ID: NCT06780358

Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography

NCT ID: NCT05204108

This clinical trial is looking at a new imaging technique called contrast-enhanced ultrasonography (CEUS) to see how well it can detect muscle invasion in bladder cancer before surgery. Knowing how...

Gender Related Coping and Survivorship for Genitourinary Cancers

NCT ID: NCT05649306

This clinical trial is focused on understanding how women with bladder cancer cope with their illness and how it affects their quality of life, particularly in terms of emotional well-being and sex...

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

NCT ID: NCT06525571

This clinical trial is studying two different methods of treating high-risk non-muscle invasive bladder cancer (NMIBC) during a procedure called transurethral resection of bladder tumor (TURBT). Re...

Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

NCT ID: NCT03291028

This clinical trial is studying patients with renal cell carcinoma (a type of kidney cancer) and urothelial carcinoma (cancer that affects the urinary system, including the bladder). Researchers wa...

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

NCT ID: NCT06732531

This clinical trial is investigating a new treatment called BH011 for patients with high-risk non-muscle invasive bladder cancer (NMIBC) who have not responded to a previous treatment called Bacill...

Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

NCT ID: NCT06762925

This clinical trial is exploring a new treatment approach for patients with bladder, prostate, and kidney cancers. The study is focused on a substance called METTL3, which researchers believe could...

Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma

NCT ID: NCT06091124

This clinical trial is studying a new treatment approach for patients with neuroendocrine carcinoma of the bladder, a type of bladder cancer. The goal is to see how well a combination of three medi...

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

NCT ID: NCT05562791

This clinical trial is investigating a new type of imaging scan called the 68Gallium PSMA-PET/CT scan to see if it is better at detecting cancer in people who have metastatic bladder cancer or skin...

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

NCT ID: NCT05057013

This clinical trial is testing a new drug called HMBD-001, which is designed to target specific cancer cells in patients with advanced solid tumors that have a high level of a protein called HER3. ...